|
1
|
Lv Z, Yang YX, Li J, Fei Y, Guo H, Sun Z,
Lu J, Xu X, Jiang Q, Ikegawa S and Shi D: Molecular classification
of knee osteoarthritis. Front Cell Dev Biol. 9:7255682021.
View Article : Google Scholar
|
|
2
|
Mintarjo JA, Poerwanto E and Tedyanto EH:
Current non-surgical management of knee osteoarthritis. Cureus.
15:e409662023.PubMed/NCBI
|
|
3
|
Onuora S: Osteoarthritis: OA chondrocytes
made senescent by genomic DNA damage. Nat Rev Rheumatol. 8:5022012.
View Article : Google Scholar
|
|
4
|
Dell'Isola A, Allan R, Smith SL, Marreiros
SS and Steultjens M: Identification of clinical phenotypes in knee
osteoarthritis: A systematic review of the literature. BMC
Musculoskelet Disord. 17:4252016. View Article : Google Scholar
|
|
5
|
Du X, Liu ZY, Tao XX, Mei YL, Zhou DQ,
Cheng K, Gao SL, Shi HY, Song C and Zhang XM: Research progress on
the pathogenesis of knee osteoarthritis. Orthop Surg. 15:2213–2224.
2023. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Peloso P, Chen W, Lin HL, Gates D, Straus
W and Moore R: (363) Pain improvement in osteoarthritis (OA)
predicts improved functioning. J Pain. 15 (Suppl):S662014.
View Article : Google Scholar
|
|
7
|
Li R, Sun J, Hu H, Zhang Q, Sun R, Zhou S,
Zhang H and Fang J: Research trends of acupuncture therapy on knee
osteoarthritis from 2010 to 2019: A bibliometric analysis. J Pain
Res. 13:1901–1913. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Georgiev T and Angelov AK: Modifiable risk
factors in knee osteoarthritis: Treatment implications. Rheumatol
Int. 39:1145–1157. 2019. View Article : Google Scholar
|
|
9
|
Zhang J, Fan F, Liu A, Zhang C, Li Q,
Zhang C, He F and Shang M: Icariin: A potential molecule for
treatment of knee osteoarthritis. Front Pharmacol. 13:8118082022.
View Article : Google Scholar
|
|
10
|
Yang X, Thudium CS, Bay-Jensen AC, Karsdal
MA, van Santen J, Arden NK, Perry TA and Kluzek S: Association
between markers of synovial inflammation, matrix turnover and
symptoms in knee osteoarthritis: A cross-sectional study. Cells.
10:18262021. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li X, Mei W, Huang Z, Zhang L, Zhang L, Xu
B, Shi X, Xiao Y, Ma Z, Liao T, et al: Casticin suppresses
monoiodoacetic acid-induced knee osteoarthritis through inhibiting
HIF-1α/NLRP3 inflammasome signaling. Int Immunopharmacol.
86:1067452020. View Article : Google Scholar
|
|
12
|
Tan Q, Cai Z, Li J, Li J, Xiang H, Li B
and Cai G: Imaging study on acupuncture inhibiting inflammation and
bone destruction in knee osteoarthritis induced by monosodium
iodoacetate in rat model. J Pain Res. 15:93–103. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jo EK, Kim JK, Shin DM and Sasakawa C:
Molecular mechanisms regulating NLRP3 inflammasome activation. Cell
Mol Immunol. 13:148–159. 2016. View Article : Google Scholar
|
|
14
|
Zhang L, Li X, Zhang H, Huang Z, Zhang N,
Zhang L, Xing R and Wang P: Agnuside alleviates synovitis and
fibrosis in knee osteoarthritis through the inhibition of HIF-1α
and NLRP3 inflammasome. Mediators Inflamm. 2021:55346142021.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sharma BR and Kanneganti TD: NLRP3
inflammasome in cancer and metabolic diseases. Nat Immunol.
22:550–559. 2021. View Article : Google Scholar
|
|
16
|
Xu J and Núñez G: The NLRP3 inflammasome:
Activation and regulation. Trends Biochem Sci. 48:331–344. 2023.
View Article : Google Scholar
|
|
17
|
Zhou R, Yazdi AS, Menu P and Tschopp J: A
role for mitochondria in NLRP3 inflammasome activation. Nature.
469:221–225. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kaufmann FN, Costa AP, Ghisleni G, Diaz
AP, Rodrigues ALS, Peluffo H and Kaster MP: NLRP3
inflammasome-driven pathways in depression: Clinical and
preclinical findings. Brain Behav Immun. 64:367–383. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Afonina IS, Zhong Z, Karin M and Beyaert
R: Limiting inflammation-the negative regulation of NF-κB and the
NLRP3 inflammasome. Nat Immunol. 18:861–869. 2017. View Article : Google Scholar
|
|
20
|
Conway R and McCarthy GM:
Calcium-containing crystals and osteoarthritis: An unhealthy
alliance. Curr Rheumatol Rep. 20:132018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kapoor M, Martel-Pelletier J, Lajeunesse
D, Pelletier JP and Fahmi H: Role of proinflammatory cytokines in
the pathophysiology of osteoarthritis. Nat Rev Rheumatol. 7:33–42.
2011. View Article : Google Scholar
|
|
22
|
Ding L, Liao T, Yang N, Wei Y, Xing R, Wu
P, Li X, Mao J and Wang P: Chrysin ameliorates synovitis and
fibrosis of osteoarthritic fibroblast-like synoviocytes in rats
through PERK/TXNIP/NLRP3 signaling. Front Pharmacol.
14:11702432023. View Article : Google Scholar
|
|
23
|
Zhao LR, Xing RL, Wang PM, Zhang NS, Yin
SJ, Li XC and Zhang L: NLRP1 and NLRP3 inflammasomes mediate
LPS/ATP-induced pyroptosis in knee osteoarthritis. Mol Med Rep.
17:5463–5469. 2018.PubMed/NCBI
|
|
24
|
Ma Z, Huang Z, Zhang L, Li X, Xu B, Xiao
Y, Shi X, Zhang H, Liao T and Wang P: Vanillic acid reduces
pain-related behavior in knee osteoarthritis rats through the
inhibition of NLRP3 inflammasome-related synovitis. Front
Pharmacol. 11:5990222021. View Article : Google Scholar
|
|
25
|
Sun C, Zhao W, Wang X, Sun Y and Chen X: A
pharmacological review of dicoumarol: An old natural anticoagulant
agent. Pharmacol Res. 160:1051932020. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chkhikvishvili I, Mamniashvili T, Gogia N,
Enukidze M, Machavariani M and Sanikidze T: Antioxidant,
anti-inflammatory activity of georgian leguminous crops cultures.
Georgian Med News. 147–153. 2017.
|
|
27
|
Timson DJ: Dicoumarol: A drug which hits
at least two very different targets in vitamin K metabolism. Curr
Drug Targets. 18:500–510. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
PERONNET, . Anticoagulants, heparin and
dicoumarol. Fr Med. 11:3–8. 1948.(In French).
|
|
29
|
Council NJP: Guide for the Care and Use of
Laboratory Animals. 8th edition. National Academies Press;
Washington, DC: pp. 963–965. 2010
|
|
30
|
Liao T, Ding L, Wu P, Zhang L, Li X, Xu B,
Zhang H, Ma Z, Xiao Y and Wang P: Chrysin attenuates the NLRP3
inflammasome cascade to reduce synovitis and pain in KOA rats. Drug
Des Devel Ther. 14:3015–3027. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cheng ST, Hu JL, Ren JH, Yu HB, Zhong S,
Wai Wong VK, Kwan Law BY, Chen WX, Xu HM, Zhang ZZ, et al:
Dicoumarol, an NQO1 inhibitor, blocks cccDNA transcription by
promoting degradation of HBx. J Hepatol. 74:522–534. 2021.
View Article : Google Scholar
|
|
32
|
Shi J, Zhao W, Ying H, Zhang Y, Du J, Chen
S, Li J and Shen B: Estradiol inhibits NLRP3 inflammasome in
fibroblast-like synoviocytes activated by lipopolysaccharide and
adenosine triphosphate. Int J Rheum Dis. 21:2002–2010. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang L, Xu J, Zhou S, Yao F, Zhang R, You
W, Dai J, Yu K, Zhang Y, Baheti T, et al: Endothelial DGKG promotes
tumor angiogenesis and immune evasion in hepatocellular carcinoma.
J Hepatol. 80:82–98. 2024. View Article : Google Scholar
|
|
34
|
Nàger M, Sallán MC, Visa A, Pushparaj C,
Santacana M, Macià A, Yeramian A, Cantí C and Herreros J:
Inhibition of WNT-CTNNB1 signaling upregulates SQSTM1 and
sensitizes glioblastoma cells to autophagy blockers. Autophagy.
14:619–636. 2018. View Article : Google Scholar
|
|
35
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bhattaram P and Chandrasekharan U: The
joint synovium: A critical determinant of articular cartilage fate
in inflammatory joint diseases. Semin Cell Dev Biol. 62:86–93.
2017. View Article : Google Scholar
|
|
37
|
Toldo S, Mezzaroma E, Buckley LF, Potere
N, Di Nisio M, Biondi-Zoccai G, Van Tassell BW and Abbate A:
Targeting the NLRP3 inflammasome in cardiovascular diseases.
Pharmacol Ther. 236:1080532022. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Shao BZ, Xu ZQ, Han BZ, Su DF and Liu C:
NLRP3 inflammasome and its inhibitors: A review. Front Pharmacol.
6:2622015. View Article : Google Scholar
|
|
39
|
He Y, Hara H and Núñez G: Mechanism and
regulation of NLRP3 inflammasome activation. Trends Biochem Sci.
41:1012–1021. 2016. View Article : Google Scholar
|
|
40
|
Lu A, Magupalli VG, Ruan J, Yin Q,
Atianand MK, Vos MR, Schröder GF, Fitzgerald KA, Wu H and Egelman
EH: Unified polymerization mechanism for the assembly of
ASC-dependent inflammasomes. Cell. 156:1193–1206. 2014. View Article : Google Scholar
|
|
41
|
Elliott EI and Sutterwala FS: Initiation
and perpetuation of NLRP3 inflammasome activation and assembly.
Immunol Rev. 265:35–52. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Shimizu H, Shimoura K, Iijima H, Suzuki Y
and Aoyama T: Functional manifestations of early knee
osteoarthritis: A systematic review and meta-analysis. Clin
Rheumatol. 41:2625–2634. 2022. View Article : Google Scholar
|
|
43
|
Rannou F and Poiraudeau S:
Non-pharmacological approaches for the treatment of osteoarthritis.
Best Pract Res Clin Rheumatol. 24:93–106. 2010. View Article : Google Scholar
|
|
44
|
Geng R, Li J, Yu C, Zhang C, Chen F, Chen
J, Ni H, Wang J, Kang K, Wei Z, et al: Knee osteoarthritis: Current
status and research progress in treatment (Review). Exp Ther Med.
26:4812023. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Okada K, Yamaguchi S, Sato Y, Enomoto T,
Ogawa Y, Ohtori S, Tahara M and Sasho T: Comparison of meniscal
extrusion and osteophyte formation at the intercondylar notch as a
predictive biomarker for incidence of knee osteoarthritis-data from
the osteoarthritis initiative. J Orthop Sci. 24:121–127. 2019.
View Article : Google Scholar
|
|
46
|
Whittaker JL, Runhaar J, Bierma-Zeinstra S
and Roos EM: A lifespan approach to osteoarthritis prevention.
Osteoarthritis Cartilage. 29:1638–1653. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Wang M, Liu L, Zhang CS, Liao Z, Jing X,
Fishers M, Zhao L, Xu X and Li B: Mechanism of traditional Chinese
medicine in treating knee osteoarthritis. J Pain Res. 13:1421–1429.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Place DE and Kanneganti TD: Recent
advances in inflammasome biology. Curr Opin Immunol. 50:32–38.
2018. View Article : Google Scholar
|
|
49
|
Samadfam R, Chouinard L, Norton K and
Smith S: Pain assessment in monosodium iodoacetate (MIA)-induced
osteoarthritis (OA) model. J Pharmacol Toxicol Methods. 68:e392013.
View Article : Google Scholar
|
